NASDAQ:NSTG - NanoString Technologies Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding NanoString Technologies Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $25.41 -0.79 (-3.02 %) (As of 12/11/2019 04:00 PM ET) Add Compare Today's Range$25.35Now: $25.41▼$26.7850-Day Range$21.01MA: $24.48▼$26.9252-Week Range$13.26Now: $25.41▼$34.78Volume288,437 shsAverage Volume489,710 shsMarket Capitalization$908.10 millionP/E RatioN/ADividend YieldN/ABeta1.16 ProfileAnalyst RatingsAdvanced ChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email NanoString Technologies, Inc provides life science tools for translational research and molecular diagnostic products worldwide. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter MAX and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. Read More… Industry, Sector and Symbol Stock Exchange NASDAQ Industry Biological products, except diagnostic Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:NSTG Previous Symbol CUSIPN/A CIK1401708 Webhttp://www.nanostring.com/ Phone206-378-6266Debt Debt-to-Equity Ratio1.51 Current Ratio4.73 Quick Ratio4.23Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$106.73 million Price / Sales8.51 Cash FlowN/A Price / Cash FlowN/A Book Value$1.20 per share Price / Book21.18Profitability EPS (Most Recent Fiscal Year)($2.78) Net Income$-77,400,000.00 Net Margins-72.30% Return on Equity-118.32% Return on Assets-41.75%Miscellaneous Employees476 Outstanding Shares35,738,000Market Cap$908.10 million Next Earnings Date3/5/2020 (Estimated) OptionableOptionable Receive NSTG News and Ratings via Email Sign-up to receive the latest news and ratings for NSTG and its competitors with MarketBeat's FREE daily newsletter. NASDAQ:NSTG Rates by TradingView NanoString Technologies (NASDAQ:NSTG) Frequently Asked Questions What is NanoString Technologies' stock symbol? NanoString Technologies trades on the NASDAQ under the ticker symbol "NSTG." How were NanoString Technologies' earnings last quarter? NanoString Technologies Inc (NASDAQ:NSTG) announced its quarterly earnings data on Monday, November, 4th. The biotechnology company reported ($0.64) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.54) by $0.10. The biotechnology company earned $30.60 million during the quarter, compared to analysts' expectations of $28.05 million. NanoString Technologies had a negative net margin of 72.30% and a negative return on equity of 118.32%. View NanoString Technologies' Earnings History. When is NanoString Technologies' next earnings date? NanoString Technologies is scheduled to release their next quarterly earnings announcement on Thursday, March 5th 2020. View Earnings Estimates for NanoString Technologies. What price target have analysts set for NSTG? 2 brokerages have issued twelve-month price targets for NanoString Technologies' stock. Their forecasts range from $28.00 to $35.00. On average, they anticipate NanoString Technologies' share price to reach $31.50 in the next twelve months. This suggests a possible upside of 24.0% from the stock's current price. View Analyst Price Targets for NanoString Technologies. What is the consensus analysts' recommendation for NanoString Technologies? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for NanoString Technologies in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for NanoString Technologies. Has NanoString Technologies been receiving favorable news coverage? News stories about NSTG stock have trended negative on Wednesday, InfoTrie reports. InfoTrie ranks the sentiment of news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. NanoString Technologies earned a media sentiment score of -3.0 on InfoTrie's scale. They also assigned news articles about the biotechnology company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near term. View News Stories for NanoString Technologies. Who are some of NanoString Technologies' key competitors? Some companies that are related to NanoString Technologies include Adaptive Biotechnologies (ADPT), Allogene Therapeutics (ALLO), Iovance Biotherapeutics (IOVA), Halozyme Therapeutics (HALO), Audentes Therapeutics (BOLD), Acceleron Pharma (XLRN), Denali Therapeutics (DNLI), Editas Medicine (EDIT), Regenxbio (RGNX), Momenta Pharmaceuticals (MNTA), Fate Therapeutics (FATE), Alector (ALEC), Coherus Biosciences (CHRS), Orchard Therapeutics (ORTX) and Krystal Biotech (KRYS). What other stocks do shareholders of NanoString Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other NanoString Technologies investors own include CA (CA), BlackRock (BLK), Endologix (ELGX), Aegean Marine Petroleum Network (ANW), Chipotle Mexican Grill (CMG), Precision Drilling (PD), AutoZone (AZO), Bank Of The Ozarks (OZRK), Designer Brands (DBI) and Eaton Vance Floating-Rate Income Trust (EFT). Who are NanoString Technologies' key executives? NanoString Technologies' management team includes the folowing people: Mr. R. Bradley Gray, CEO, Pres & Director (Age 42)Mr. K. Thomas Bailey M.B.A., CFO & Treasurer (Age 50)Dr. Mary Tedd Allen, Sr. VP of Operations & Admin. (Age 56)Dr. Joseph M. Beechem, Sr. VP of R&D (Age 61)Mr. David W. Ghesquiere, Sr. VP of Corp. & Bus. Devel. (Age 52) Who are NanoString Technologies' major shareholders? NanoString Technologies' stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Sumitomo Mitsui Trust Holdings Inc. (11.05%), Nikko Asset Management Americas Inc. (11.02%), Pictet Asset Management Ltd. (2.17%), State Street Corp (1.87%), Millennium Management LLC (1.44%) and Rhenman & Partners Asset Management AB (0.40%). Company insiders that own NanoString Technologies stock include Charles P Waite, Jr, David W Ghesquiere, J Chad Brown, K Thomas Bailey, Kirk Malloy, Lifesciences Ii LP Clarus, Mary Tedd Allen, Nicholas Galakatos, R Bradley Gray and William Young. View Institutional Ownership Trends for NanoString Technologies. Which institutional investors are selling NanoString Technologies stock? NSTG stock was sold by a variety of institutional investors in the last quarter, including Castleark Management LLC, Man Group plc, Columbus Circle Investors, Russell Investments Group Ltd., Squarepoint Ops LLC, Strs Ohio, First Mercantile Trust Co. and Conestoga Capital Advisors LLC. Company insiders that have sold NanoString Technologies company stock in the last year include Charles P Waite, Jr, David W Ghesquiere, J Chad Brown, K Thomas Bailey, Kirk Malloy, Lifesciences Ii LP Clarus, Mary Tedd Allen, R Bradley Gray and William Young. View Insider Buying and Selling for NanoString Technologies. Which institutional investors are buying NanoString Technologies stock? NSTG stock was acquired by a variety of institutional investors in the last quarter, including Sumitomo Mitsui Trust Holdings Inc., Nikko Asset Management Americas Inc., Pictet Asset Management Ltd., Millennium Management LLC, Fisher Asset Management LLC, State of New Jersey Common Pension Fund D, SG Americas Securities LLC and California Public Employees Retirement System. View Insider Buying and Selling for NanoString Technologies. How do I buy shares of NanoString Technologies? Shares of NSTG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab. What is NanoString Technologies' stock price today? One share of NSTG stock can currently be purchased for approximately $25.41. How big of a company is NanoString Technologies? NanoString Technologies has a market capitalization of $908.10 million and generates $106.73 million in revenue each year. The biotechnology company earns $-77,400,000.00 in net income (profit) each year or ($2.78) on an earnings per share basis. NanoString Technologies employs 476 workers across the globe.View Additional Information About NanoString Technologies. What is NanoString Technologies' official website? The official website for NanoString Technologies is http://www.nanostring.com/. How can I contact NanoString Technologies? NanoString Technologies' mailing address is 530 FAIRVIEW AVENUE NORTH SUITE 2000, SEATTLE WA, 98109. The biotechnology company can be reached via phone at 206-378-6266 or via email at [email protected] MarketBeat Community Rating for NanoString Technologies (NASDAQ NSTG)Community Ranking: 2.6 out of 5 ( )Outperform Votes: 408 (Vote Outperform)Underperform Votes: 391 (Vote Underperform)Total Votes: 799MarketBeat's community ratings are surveys of what our community members think about NanoString Technologies and other stocks. Vote "Outperform" if you believe NSTG will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NSTG will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 12/11/2019 by MarketBeat.com StaffFeatured Article: Forex